371 related articles for article (PubMed ID: 20534348)
1. Interplay between the ribosomal tunnel, nascent chain, and macrolides influences drug inhibition.
Starosta AL; Karpenko VV; Shishkina AV; Mikolajka A; Sumbatyan NV; Schluenzen F; Korshunova GA; Bogdanov AA; Wilson DN
Chem Biol; 2010 May; 17(5):504-14. PubMed ID: 20534348
[TBL] [Abstract][Full Text] [Related]
2. Conjugates of amino acids and peptides with 5-o-mycaminosyltylonolide and their interaction with the ribosomal exit tunnel.
Shishkina A; Makarov G; Tereshchenkov A; Korshunova G; Sumbatyan N; Golovin A; Svetlov M; Bogdanov A
Bioconjug Chem; 2013 Nov; 24(11):1861-9. PubMed ID: 24090034
[TBL] [Abstract][Full Text] [Related]
3. Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel.
Kannan K; Vázquez-Laslop N; Mankin AS
Cell; 2012 Oct; 151(3):508-20. PubMed ID: 23101624
[TBL] [Abstract][Full Text] [Related]
4. Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.
Kannan K; Mankin AS
Ann N Y Acad Sci; 2011 Dec; 1241():33-47. PubMed ID: 22191525
[TBL] [Abstract][Full Text] [Related]
5. Cis-acting resistance peptides reveal dual ribosome inhibitory action of the macrolide josamycin.
Lovmar M; Vimberg V; Lukk E; Nilsson K; Tenson T; Ehrenberg M
Biochimie; 2009 Aug; 91(8):989-95. PubMed ID: 19463886
[TBL] [Abstract][Full Text] [Related]
6. On the mechanism of action of 9-O-arylalkyloxime derivatives of 6-O-mycaminosyltylonolide, a new class of 16-membered macrolide antibiotics.
Karahalios P; Kalpaxis DL; Fu H; Katz L; Wilson DN; Dinos GP
Mol Pharmacol; 2006 Oct; 70(4):1271-80. PubMed ID: 16873579
[TBL] [Abstract][Full Text] [Related]
7. Context-specific action of macrolide antibiotics on the eukaryotic ribosome.
Svetlov MS; Koller TO; Meydan S; Shankar V; Klepacki D; Polacek N; Guydosh NR; Vázquez-Laslop N; Wilson DN; Mankin AS
Nat Commun; 2021 May; 12(1):2803. PubMed ID: 33990576
[TBL] [Abstract][Full Text] [Related]
8. Statics of the ribosomal exit tunnel: implications for cotranslational peptide folding, elongation regulation, and antibiotics binding.
Fulle S; Gohlke H
J Mol Biol; 2009 Mar; 387(2):502-17. PubMed ID: 19356596
[TBL] [Abstract][Full Text] [Related]
9. Ribosomal tunnel and translation regulation.
Bogdanov AA; Sumbatyan NV; Shishkina AV; Karpenko VV; Korshunova GA
Biochemistry (Mosc); 2010 Dec; 75(13):1501-16. PubMed ID: 21417991
[TBL] [Abstract][Full Text] [Related]
10. Visualizing the 16-membered ring macrolides tildipirosin and tilmicosin bound to their ribosomal site.
Poehlsgaard J; Andersen NM; Warrass R; Douthwaite S
ACS Chem Biol; 2012 Aug; 7(8):1351-5. PubMed ID: 22563863
[TBL] [Abstract][Full Text] [Related]
11. Ribosomal crystallography: peptide bond formation and its inhibition.
Bashan A; Zarivach R; Schluenzen F; Agmon I; Harms J; Auerbach T; Baram D; Berisio R; Bartels H; Hansen HA; Fucini P; Wilson D; Peretz M; Kessler M; Yonath A
Biopolymers; 2003 Sep; 70(1):19-41. PubMed ID: 12925991
[TBL] [Abstract][Full Text] [Related]
12. On the use of the antibiotic chloramphenicol to target polypeptide chain mimics to the ribosomal exit tunnel.
Mamos P; Krokidis MG; Papadas A; Karahalios P; Starosta AL; Wilson DN; Kalpaxis DL; Dinos GP
Biochimie; 2013 Sep; 95(9):1765-72. PubMed ID: 23770443
[TBL] [Abstract][Full Text] [Related]
13. Translation and protein synthesis: macrolides.
Katz L; Ashley GW
Chem Rev; 2005 Feb; 105(2):499-528. PubMed ID: 15700954
[No Abstract] [Full Text] [Related]
14. A peptide deformylase-ribosome complex reveals mechanism of nascent chain processing.
Bingel-Erlenmeyer R; Kohler R; Kramer G; Sandikci A; Antolić S; Maier T; Schaffitzel C; Wiedmann B; Bukau B; Ban N
Nature; 2008 Mar; 452(7183):108-11. PubMed ID: 18288106
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin.
Poulsen SM; Kofoed C; Vester B
J Mol Biol; 2000 Dec; 304(3):471-81. PubMed ID: 11090288
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of drug-ribosome interactions defines the cidality of macrolide antibiotics.
Svetlov MS; Vázquez-Laslop N; Mankin AS
Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13673-13678. PubMed ID: 29229833
[TBL] [Abstract][Full Text] [Related]
17. Peptide-mediated macrolide resistance reveals possible specific interactions in the nascent peptide exit tunnel.
Vimberg V; Xiong L; Bailey M; Tenson T; Mankin A
Mol Microbiol; 2004 Oct; 54(2):376-85. PubMed ID: 15469510
[TBL] [Abstract][Full Text] [Related]
18. Macrolide-peptide conjugates as probes of the path of travel of the nascent peptides through the ribosome.
Washington AZ; Benicewicz DB; Canzoneri JC; Fagan CE; Mwakwari SC; Maehigashi T; Dunham CM; Oyelere AK
ACS Chem Biol; 2014 Nov; 9(11):2621-31. PubMed ID: 25198768
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of drug-dependent ribosome stalling.
Vazquez-Laslop N; Thum C; Mankin AS
Mol Cell; 2008 Apr; 30(2):190-202. PubMed ID: 18439898
[TBL] [Abstract][Full Text] [Related]
20. Binding of Macrolide Antibiotics Leads to Ribosomal Selection against Specific Substrates Based on Their Charge and Size.
Sothiselvam S; Neuner S; Rigger L; Klepacki D; Micura R; Vázquez-Laslop N; Mankin AS
Cell Rep; 2016 Aug; 16(7):1789-99. PubMed ID: 27498876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
